Sangamo Therapeutics Inc (SGMO) concluded trading on Wednesday at a closing price of $0.56, with 262.28 million shares of worth about $146.88 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 23.29% during that period and on July 24, 2024 the price saw a gain of about 39.55%. Currently the company’s common shares owned by public are about 207.51M shares, out of which, 186.71M shares are available for trading.
Stock saw a price change of 28.44% in past 5 days and over the past one month there was a price change of 19.20%. Year-to-date (YTD), SGMO shares are showing a performance of 3.07% which decreased to -57.58% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.29 but also hit the highest price of $1.48 during that period. The average intraday trading volume for Sangamo Therapeutics Inc shares is 2.27 million. The stock is currently trading 43.51% above its 20-day simple moving average (SMA20), while that difference is up 13.66% for SMA50 and it goes to 0.19% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sangamo Therapeutics Inc (NASDAQ: SGMO) currently have 207.51M outstanding shares and institutions hold larger chunk of about 49.04% of that.
The stock has a current market capitalization of $116.21M and its 3Y-monthly beta is at 1.24. It has posted earnings per share of -$1.86 in the same period. It has Quick Ratio of 1.71 while making debt-to-equity ratio of 0.54. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SGMO, volatility over the week remained 26.83% while standing at 16.47% over the month.
Stock’s fiscal year EPS is expected to rise by 64.58% while it is estimated to increase by 65.94% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on November 03, 2023 offering a Sector perform rating for the stock and assigned a target price range of between $6 and $2 to it. Coverage by BofA Securities stated Sangamo Therapeutics Inc (SGMO) stock as an Underperform in their note to investors on April 28, 2023, suggesting a price target of $1.50 for the stock. On February 27, 2023, Wedbush Upgrade their recommendations, while on January 06, 2023, BofA Securities Downgrade their ratings for the stock with a price target of $5. Stock get a Neutral rating from Wedbush on June 13, 2022.
